Facebook
Twitter
LinkedIn
ForwardHow to Succeed in Stopping the Bleed: Hemophilia Overview
April 4, 2025
This webinar will provide an in-depth review of hemophilia A and B, focusing on the latest management strategies and novel treatment options, particularly in the pediatric population. Participants will learn about the pathophysiology and inheritance patterns of hemophilia, current management options, and the use of new drugs for prophylaxis. The webinar will also cover the management of bleeding episodes and the role of comprehensive care teams.
Target Audience
- Pharmacists
- Other Healthcare Professionals
Learning Objectives
At the conclusion of this activity, pharmacists should be able to:
- Describe pathophysiology and inheritance patterns of hemophilia A and B
- Identify currently available hemophilia management options
- Analyze recommended prophylactic products and nonfactor therapies for preventing bleeding in patients with hemophilia A and B
FACULTY & PLANNERS
Faculty
Ashton O'Hara, PharmD
PGY2 Pediatric Pharmacy Resident
Children's Hospital of Richmond at VCU
PGY2 Pediatric Pharmacy Resident
Children's Hospital of Richmond at VCU
Planning Committee
Sybil Thomas, PharmD
AVP, Member Connections
Vizient, Inc.
Mital Desai, PharmD
Director, Pharmacy Network
Vizient, Inc.
Samantha Gordon, MS
CE Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education
Vizient, Inc.
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s)
Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.0 contact hours for pharmacists.
Universal Activity Number: JA0006103-0000-25-030-L01-P
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 General CE - Attendance
Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
Please Note:
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
- This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.